Articles by Disease (Amyotrophic Lateral Sclerosis)

Topical Delivery of Drugs for the Effective Treatment of Fungal Infections of Skin

Journal: Current Pharmaceutical Design
Volume: 21
Page: 2892-2913
Author(s): Nida Akhtar, Anurag Verma and Kamla Pathak

Meet Our Editorial Board Member:

Journal: Current Alzheimer Research
Volume: 12
Page: 399-399
Author(s): Jack T. Rogers

Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling

Journal: Current Medicinal Chemistry
Volume: 22
Page: 2004-2021
Author(s): Giovanna Morello, Francesca Luisa Conforti, Rosalba Parenti, Velia D’Agata and Sebastiano Cavallaro

Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight

Journal: Current Neuropharmacology
Volume: 13
Page: 258-265
Author(s): Nicolai E. Savaskan, Zheng Fan, Thomas Broggini, Michael Buchfelder and Ilker Y. Eyüpoglu

VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 15
Page: 135-144
Author(s): Masabumi Shibuya

New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14
Page: 677-686
Author(s): Cinzia Volonte, Chiara Parisi and Savina Apolloni

Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca²⁺ Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14
Page: 636-646
Author(s): Elisabetta Gerace, Domenico E. Pellegrini-Giampietro, Flavio Moroni and Guido Mannaioni